Home Cart 0 Sign in  

[ CAS No. 13815-94-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 13815-94-6
Chemical Structure| 13815-94-6
Structure of 13815-94-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 13815-94-6 ]

Related Doc. of [ 13815-94-6 ]

Alternatived Products of [ 13815-94-6 ]

Product Details of [ 13815-94-6 ]

CAS No. :13815-94-6 MDL No. :MFCD00149845
Formula : Cl3H6O3Ru Boiling Point : -
Linear Structure Formula :- InChI Key :ZTWIEIFKPFJRLV-UHFFFAOYSA-K
M.W : 261.47 Pubchem ID :12090026
Synonyms :

Calculated chemistry of [ 13815-94-6 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 0
Fraction Csp3 : None
Num. rotatable bonds : 0
Num. H-bond acceptors : None
Num. H-bond donors : None
Molar Refractivity : 26.7
TPSA : 27.69 Ų

Pharmacokinetics

GI absorption : None
BBB permeant : None
P-gp substrate : None
CYP1A2 inhibitor : None
CYP2C19 inhibitor : None
CYP2C9 inhibitor : None
CYP2D6 inhibitor : None
CYP3A4 inhibitor : None
Log Kp (skin permeation) : None cm/s

Lipophilicity

Log Po/w (iLOGP) : None
Log Po/w (XLOGP3) : None
Log Po/w (WLOGP) : None
Log Po/w (MLOGP) : None
Log Po/w (SILICOS-IT) : None
Consensus Log Po/w : None

Druglikeness

Lipinski : None
Ghose : None
Veber : None
Egan : None
Muegge : None
Bioavailability Score : None

Water Solubility

Log S (ESOL) : None
Solubility : None mg/ml ; None mol/l
Class : None
Log S (Ali) : None
Solubility : None mg/ml ; None mol/l
Class : None
Log S (SILICOS-IT) : None
Solubility : None mg/ml ; None mol/l
Class : None

Medicinal Chemistry

PAINS : None alert
Brenk : None alert
Leadlikeness : None
Synthetic accessibility : None

Safety of [ 13815-94-6 ]

Signal Word:Danger Class:8
Precautionary Statements:P260-P264-P270-P273-P280-P301+P312+P330-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P391-P405-P501 UN#:3260
Hazard Statements:H302-H314-H411 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 13815-94-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 13815-94-6 ]

[ 13815-94-6 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 366-18-7 ]
  • [ 14898-67-0 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
93% With D-glucose; ascorbic acid In water; ethylene glycol Sonication; under Ar; to hot (110°C) degassed ethanediol-water (3:1) was added RuCl3 (4.1 mmol); after 15 min a ligand (8.3 mmol) was added; after 15min glucose (8 mmol) and again after 15 min L-ascorbic acid (2.2 mmol) were added; after keeping at 110°C for 30 min, mixt. was cooled, brine was added; keeping at 0°C for 1 h; complex was filtered, washed with brine and toluene/ether/acetone mixt.; sonication in CH2Cl2; toluene addn.; CH2Cl2 was removed under vac.;
73% With lithium chloride In methanol; N,N-dimethyl-formamide reflux (8 h), cooling to room temp.; addn. (acetone), crystn. (freezer, overnight), filtration, washing (water and ether), drying (air);
70% With D-glucose; lithium chloride; ascorbic acid In water; ethylene glycol Sonication; under Ar; to hot (110°C) soln. of LiCl (22 mmol) in degassed ethanediol-water (3:1) was added RuCl3 (4.1 mmol); after 15 min a ligand (8.3 mmol) was added; after 15 min glucose (8 mmol) and again after 15 min L-ascorbic acid (2.2 mmol) were added; after keeping at 110°C for 30 min, mixt. was cooled, brine was added; keeping at 0°C for 1 h; complex was filtered, washed with brine and toluene/ether/acetone mixt.; sonication in CH2Cl2; toluene addn.; CH2Cl2 was removed under vac.;
61% With sodium chloride; ascorbic acid; Sucrose In hydrogenchloride Sonication; under Ar; to hot (100°C) and degassed soln. of NaCl, sucrose and a ligand (8.3 mmol) in a mixt. of concd. aq. HCl:H2O 3:10 was added RuCl3 (4.2 mmol); after 15 min L-ascorbic acid was added; the mixt. was keptat that temp. for 15 min; cooling; the ppt. was collected by filtration, washed with brine, and dried in vac.; then it was washed with ether and toluene and extd. with CH2Cl2; toluene was added to the ext.; concn. in vac.;
61% With lithium chloride In N,N-dimethyl-formamide reflux (8 h), cooling to room temp.; addn. (acetone), crystn. (freezer, overnight), filtration, washing (water and ether), drying (air);
55-60 In N,N-dimethyl-formamide; acetone mixt. of bpy and RuCl3*3H2O (molar ratio 2:1) in DMF, refluxing, 1.5 h, heating, 2 h, addn. of acetone, cooling (ice bath); collection (filtration), washing (water), recrystn. (dissolving in ethanol/water(1:1), addn. of LiCl, vol. reducing until b.p. reached, slow cooling to room temp.), filtration, washing (H2O), drying (vac.);

Same Skeleton Products
Historical Records